Home » Topics » Regulatory

Regulatory
RSS

ATP-sensitive K+ channel blockers reportedly useful for vagal nervous system dysfunction

April 24, 2000

CV Therapeutics develops sustained-release formulations of ranolazine

April 24, 2000

Humalog now available in Europe to treat children with diabetes

April 24, 2000

FDA approves first oxazolidinone antimicrobial drug

April 20, 2000

Antihistamines reported useful by Schering-Plough for Rx of sinusitis and otitis media

April 20, 2000

FDA approves Actonel for osteoporosis prevention and treatment

April 20, 2000

Taxol approved in Canada for adjuvant treatment of breast cancer

April 19, 2000

FDA approves Mobic for osteoarthritis symptom relief

April 18, 2000

Celecoxib: use in inflammatory conditions of the head and neck

April 18, 2000

Sanofi-Synthelabo begins rolling out Xatral XL in Europe

April 18, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...